| Financial Year |
March 31 2023 |
| Monetary Funds |
353,461,750.11 |
| Held-for-trading Financial Assets |
10,365,154.78 |
| Notes Receivable |
5,797,512.44 |
| Accounts Receivable |
555,802,549.71 |
| Advances to Suppliers |
72,582,606.34 |
| Other Receivables |
47,467,555.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
533.01 |
| Dividend Receivable |
-- |
| Inventories |
1,134,209,233.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,341,845.47 |
| Total Current Assets |
2,372,767,158.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,708,100.10 |
| Fixed Assetes |
296,092,097.31 |
| Under-construction Projects |
39,735.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,488,172.04 |
| R&D expenses |
-- |
| Goodwill |
65,441,422.71 |
| Long-Term Deferred and Prepaid Expenses |
975,061.68 |
| Deferred Income Tax Assets |
27,420,041.12 |
| Other Non-Current Assets |
9,171,109.09 |
| Sub-Total of Non-Current Assets |
488,963,691.63 |
| Total Assets |
2,861,730,850.15 |
| Short-Term Loans |
421,946,221.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,170,820.00 |
| Accounts Payable |
388,709,871.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,114,247.12 |
| Taxes Payable |
22,590,605.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,414,063.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,104,847.01 |
| Other Current Liabilities |
29,653,928.37 |
| Sub-Total of Current Liabilities |
1,733,886,105.76 |
| Long-term Loans |
84,608,757.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,303,817.54 |
| Other Non-Current Liabilities |
12,928,888.87 |
| Sub-Total of Non-Current Liabilities |
172,441,612.70 |
| Total Liabilities |
1,906,327,718.46 |
| Paid-In Capital(Or Share Stock) |
112,518,866.00 |
| Capital Surplus |
352,335,512.57 |
| Surplus Reserve |
55,724,530.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
418,784,903.20 |
| Minority Stockholder's Interest |
15,135,229.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
940,267,902.46 |
| Owner's Equity（Stockholder's Equity） |
955,403,131.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,861,730,850.15 |
